Analyst Ratings For Acorda Therapeutics (NASDAQ:ACOR)
Today, Stifel Nicolaus reiterated its Buy rating on Acorda Therapeutics (NASDAQ:ACOR).
There are 6 hold ratings, 3 buy ratings on the stock.
The current consensus rating on Acorda Therapeutics (NASDAQ:ACOR) is Hold (Score: 2.33) with a consensus target price of $24.67 per share, a potential 13.67% upside.
Some recent analyst ratings include
- 7/28/2017-Stifel Nicolaus Reiterated Rating of Buy.
- 7/10/2017-Jefferies Group LLC initiated coverage with a Hold rating.
- 6/7/2017-Cowen and Company Reiterated Rating of Outperform.
- 4/3/2017-Goldman Sachs Group, Inc. (The) Reiterated Rating of Neutral.
- 4/3/2017-Janney Montgomery Scott was Downgraded by analysts at Janney Montgomery Scott from a “Buy ” rating to a ” Neutral” rating. They now have a $19.00 price target on the stock, up previously from $38.00 .
- 2/15/2017-Cantor Fitzgerald Reiterated Rating of Neutral .
- On 6/16/2017 Ron Cohen, Insider, bought 20,000 with an average share price of $16.95 per share and the total transaction amounting to $339,000.00. View SEC Filing
- On 5/15/2017 Andrew A Hindman, Insider, sold 7,704 with an average share price of $15.75 per share and the total transaction amounting to $121,338.00. View SEC Filing
- On 12/14/2016 Ron Cohen, Insider, sold 40,172 with an average share price of $20.75 per share and the total transaction amounting to $833,569.00. View SEC Filing
- On 10/21/2016 Richard P Batycky, Insider, sold 2,063 with an average share price of $20.30 per share and the total transaction amounting to $41,878.90. View SEC Filing
- On 10/7/2016 David Lawrence, Insider, sold 250 with an average share price of $20.82 per share and the total transaction amounting to $5,205.00. View SEC Filing
- On 10/3/2016 Jane Wasman, Insider, sold 3,750 with an average share price of $20.78 per share and the total transaction amounting to $77,925.00. View SEC Filing
- On 9/23/2016 Jane Wasman, Insider, sold 500 with an average share price of $27.32 per share and the total transaction amounting to $13,660.00. View SEC Filing
Recent Trading Activity for Acorda Therapeutics (NASDAQ:ACOR)
Shares of Acorda Therapeutics closed the previous trading session at 21.70 down -0.85 -3.77% with 893,914 shares trading hands.